kathy elizabeth magliato, md, mba, facs · kathy elizabeth magliato, md, mba, facs 5 revised...

Kathy Elizabeth Magliato, MD, MBA, FACS

CURRICULUM VITAE

BUSINESS ADDRESS: Saint John’s Medical Center Department of Cardiothoracic Surgery, CTOC 2001 Santa Monica Blvd, suite 1060 Santa Monica, CA 90404

WEBSITE KATHYMAGLIATO.COM

BUSINESS PHONE: (310) 829-8618 BUSINESS FAX: (310) 829-8607


2 Revised 02/13/12

EDUCATION AND TRAINING

Undergraduate 1981 – 1985 Union College

Schenectady, NY B.S. Biochemistry

Cum Laude

Graduate 1986 – 1988 Albany Medical College

Albany, NY

M.D.

1988 – 1990 Case Western Reserve University Cleveland, OH

M.D. Alpha Omega Alpha

2004 – 2006 UCLA Anderson School of Management Los Angeles, CA

MBA Field study dissertation Johnson & Johnson Inc “Effective Corporate Disaster Response” Conrad Persons – J&J Advisor

Post-Graduate Training 1990 – 1991 Akron General Medical Center

Akron, OH

Internship, General Surgery

Daniel P. Guyton, MD

1991 – 1993 1992 (4 mo)

Akron General Medical Center Akron, OH Vanderbilt Medical Center

Junior Resident, General Surgery Surgical Critical Care Rotation

Daniel P. Guyton, MD Loren Nelson, MD

1993 – 1994 University of Michigan Medical Center Ann Arbor, MI

Research Fellow, Cardiothoracic Surgery

G. Michael Deeb, MD Steven Bolling, MD

1994 – 1995 Akron General Medical Center Senior Resident, Daniel Guyton, MD


3 Revised 02/13/12

Akron, OH

General Surgery

1995 – 1996 Akron General Medical Center Akron, OH

Chief Resident, General Surgery

Daniel P. Guyton, MD

1996 – 1998 1998 – 1999

Loyola University Medical Center Maywood, IL University of Pittsburgh Medical Center Pittsburgh, PA

Resident, Cardiothoracic Surgery Fellow, Heart and Lung Transplantation, Ventricular Assist Devices

Michael Bakhos, MD Robert L. Kormos, MD Bartley P. Griffith, MD


4 Revised 02/13/12

APPOINTMENTS AND POSITIONS

1998 – 1999 University of Pittsburgh Medical Center, Pittsburgh, PA

Clinical Instructor, Heart And Lung Transplantation Ventricular Assist Devices

1999 – 2005 Cedars-Sinai Medical Center, Los Angeles, CA

Attending Staff Surgeon, Cardiothoracic Surgery Heart/Lung Transplantation Director of the Mechanical Assist Device Program

1999 – 2006

Brotman Medical Center Culver City, CA

Attending Staff Surgeon, Cardiothoracic Surgery

1999 – 2001 Valley Presbyterian Hospital Van Nuys, CA

Attending Staff Surgeon, Cardiothoracic Surgery

2006 - present Saint John’s Medical Center Santa Monica, CA

Director of Women’s Cardiac Services Department of Cardiothoracic Surgery


5 Revised 02/13/12

COMMITTEES 2001 – 2005 2001 – 2005 2002 – 2005 2002 – 2005 2003 – 2004 2003 – 2004 2006 - present

Cedars-Sinai Medical Center Los Angeles, CA Cedars-Sinai Medical Center Los Angeles, CA Cedars-Sinai Medical Center Los Angeles, CA Cedars-Sinai Medical Center Los Angeles, CA Cedars-Sinai Medical Center Los Angeles, CA Cedars-Sinai Medical Center Los Angeles, CA Saint John’s Health Center

Chairman, Multi-organ Transplant Committee Voting Member, UNOS Region 5 Thoracic Regional Review Board Board Member, Committee on Women’s Health Board Member, Women’s Health Executive Advisory Board Committee Member, Pharmacy and Therapeutics Committee Board Member, IRB Committee Committee Member, Transfusion Committee


6 Revised 02/13/12

PROGRAM DEVELOPMENT

Ventricular Assist Device Program, Cedars Sinai Medical Center, Los Angeles, CA Constructed, directed and developed a VAD program from inception to production and growth. Developed clinical expertise in VAD implantation by creating a multidisciplinary team

Devised protocols for patient selection, critical care, anticoagulation, weaning, nutrition, rehabilitation, discharge planning, psychosocial issues Created order sets specific to VAD patients Implemented a center-wide data base and case conference review Clinical research for presentation/publication Quality measures review Financial analysis Billing/coding education seminars Community education programs Local/regional Emergency Department and EMS education

International Health Program, Saint John’s Health Center (SJHC), Santa Monica, CA

Established a patient referral program (for all hospital service lines) between Guam, an unincorporated territory of the United States, and SJHC Negotiated contracts between SJHC and healthcare providers of Guam which pay at a premium (130% of Medicare rates for MD’s, 65% of hospital charges for SJHC) Established a clinical presence on Guam through quarterly trips to Guam and working in patient care clinics with local MD’s Provided educational seminars to Guam physicians Established a Guam community lecture program which emphasizes preventative measures Establishment of a 501c3 nonprofit, World Medical Care Mission, to assist with costs Fundraising for the World Medical Care Mission Quarterly financial analysis review

Women’s Health Program, Saint John’s Health Center, Santa Monica CA Created a 3-tier business plan for a multidisciplinary Women’s Health Center Hosted a UCLA Anderson field study utilizing Executive MBA students to perform a feasibility study

Implemented and funded the business plan throughout the medical center Leading role in fundraising for the Women’s Health Program


7 Revised 02/13/12

Transfusion-Free / Patient Blood Management Program, Saint John’s Health Center, Santa Monica, CA

Similar to the International Health Program, this program was established to refer patients to all hospital service lines who are unwilling to have a blood/blood product transfusion due to personal beliefs Established Saint John’s Health Center as a referral base for Liaison Committees throughout the US Perfected bloodless techniques pre-operatively, intra-operatively and post-operatively for cardiac patients Financial analysis Database construction Quality measures


8 Revised 02/13/12

CERTIFICATION AND LICENSURE

Certification

1990, 1995 November 18, 2009

Advanced Cardiac Life Support Most recent ACLS recertification

1990, 1995, 2002 November 18, 2009

Basic Life Support Most recent BLS recertification

1990 Advanced Trauma Life Support

1991 Diplomat, National Board of Medical Examiners 1997

Diplomat, American Board of Surgery

1999 2006 2008

Diplomat, American Board of Thoracic Surgery Recertification, American Board of Surgery Recertification, American Board of Thoracic Surgery

Professional Licensure 1990

State of Ohio

1993

State of Michigan

1996

State of Illinois

1998

State of Pennsylvania

1999 2010

State of California Guam


9 Revised 02/13/12

MEMBERSHIP IN PROFESSIONAL AND SCIENTIFIC SOCIETIES

Sigma Xi Research Society 1985

Alpha Omega Alpha Honor Society 1989

American College of Surgeons, Fellow 1990

Midwest Chapter, American College of Surgeons 1990

Women in Cardiothoracic Surgery 1995

Society of Thoracic Surgeons, Candidate Group 1996

International Society for Heart and Lung Transplantation 1996

Los Angeles American Medical Women Association Southern California Chapter, American College of Surgeons

1999 2000

Association of Women Surgeons American Society for Artificial Internal Organs

2000 2000

Society of Thoracic Surgeons, Active Member

2004


10 Revised 02/13/12

HONORS AND AWARDS: ACADEMIC

Multiple Dean’s List Commendations Union College, Schenectady, NY

1981 – 1985

Cum Laude Graduate Union College, Schenectady, NY

1985

Departmental Honors Distinction in Research Union College, Schenectady, NY

1985

Sigma Xi Research Society Award Union College, Schenectady, NY

1985

Fuller Academic Scholarship Union College, Schenectady, NY

1985

Bruce M. Garber Academic Award Union College, Schenectady, NY

1985

Dean’s Award for Outstanding Research Albany Medical College, Albany, NY

1987

Alpha Omega Alpha Medical Honor Society Case Western Reserve University, Cleveland, OH

1989

Milton B. Schweid Memorial Award for Excellence in Cardiovascular Diseases, Case Western Reserve University, Cleveland, OH

1990

Janet M. Glasgow Memorial Achievement Award Case Western Reserve University, Cleveland, OH

1990

Cleveland Surgical Society Research Presentation, First Place Award

1994

Akron General Medical Center Resident Research Forum Research Presentation, First Place Award

1994

American College of Surgeons, Ohio Chapter Research Presentation, First Place Award

1995

Cleveland Surgical Society, Research Presentation, First Place Award

1995


11 Revised 02/13/12

Akron General Medical Center Resident Research Forum Research Presentation, First Place Award Fellow of the American College of Surgeons (FACS) San Francisco, CA

HONORS AND AWARDS: NON-ACADEMIC Women’s Leadership Exchange Compass Award New York City, NY Red Cross Humanitarianism Award Co-honoree: Shonda Rhimes and the cast of Grey’s Anatomy Beverly Hills, CA American Heart Association Top Heart Walk Fundraiser Exceptional Women Award, Magic 106.7 Co-honoree: Kate White, editor-in-chief, Cosmopolitan Magazine Boston, MA 100 Most Inspirational Alumni Award UCLA Anderson School of Management 75th year institutional anniversary

1995 2005 2003 2008 2008, 2010 2010 2010


12 Revised 02/13/12

RESEARCH EXPERIENCE

Loyola University Medical Center, Maywood, Illinois

July 1997 - June 1998

Laboratory research project which studies the effects of antegrade versus retrograde cardioplegia on the production of free radical markers and myocardial injury using a canine cardiopulmonary bypass model and myocardial microdialysis. HPLC analysis of xanthine, hypoxanthine, adenosine, inosine, ATP, AMP.

Leroy L. Hirsch, M.D. Professor, Cardiopulmonary Physiology and Anesthesiology

Bradford P. Blakeman, M. D. Vice Chairman, Department of Cardiothoracic Surgery

University of Michigan Medical Center, Ann Arbor, Michigan

July 1993 – July 1994

Cardiothoracic Research Fellowship – Ischemia Reperfusion Injury, Cytokines, Rat Lung Transplant Model.

G. Michael Deeb, M.D. Director, Adult Cardiac Surgery Director, Heart/Lung Transplantation and Artificial Devices Program

Robert M. Strieter, M.D. Associate Professor of Internal Medicine Director of Pulmonary and Critical Care


13 Revised 02/13/12

Albany Medical Center, Albany, New York

August 1986 – August 1987

Surgical Oncology Research Fellowship – Characterization of Natural Killer Cell Activity, Effects of IL-2.

Frederick C. Lane, M.D. Chairman, Department of Surgical Oncology

Wadsworth Research Center, Albany, New York

August 1985 – August 1986

Neurosurgery Research Assistant – Spinal Cord Transection, Restoration of Motor Function.

Jonathan R. Wolpaw, M.D. Director, Neurosurgery Primate Research Facility New York State Department of Health

Union College, Schenectady, New York June 1984 – June 1985

Research Fellowship, Departmental Honors Program – Reproductive Neuroendocrinology.

George Butterstein, Ph.D. Professor, Neuroendocrinology and Immunology


14 Revised 02/13/12

SEMINARS AND INVITED LECTURESHIPS

Magliato, KE, and Melio, FA. Reproductive neuroendocrine responses to 6-methoxy benzoxazolinone (6-MBOA), a naturally occurring plant compound

Departmental Honors Thesis Presentation Union College, Schenectady, NY, April 1985

Sigma Xi Research Society Presentation Union College, Schenectady, NY, April 1985

Magliato, KE, Noonan, PA, Wolpaw, JR. Primate spinal reflexes after cord transection: absence of depression

16th Annual Meeting of the Society for Neuroscience Washington, DC, November 1986

Magliato, KE, Lane, FC, Mehta, JR. Characterization of the natural killer cell activity released from proliferating human lymphocytes in the presence of interleukin-2

AMA Education and Research Foundation Eastern Student Research Forum University of Miami Medical Center, March 1988

Associated Medical Schools of New York Research Forum New York University Medical Center, May 1988

Magliato, KE, Swiderski, DL, Kunkel, SL, Wilke, CA, Burdick, MD, Deeb, GM, Strieter, RM. Increased chemokine expression in response to reimplantation: rat lung transplantation Federation of American Societies for Experimental Biology Anaheim, CA, April 1994 Cleveland Surgical Society Cleveland, OH, March 1994 Magliato, KE, Swiderski, DL, Kunkel, SL, Wilke, CA, Burdick, MD, Deeb, GM, Strieter, RM. Rat lung transplantation: the expression of C-X-C chemokines in response to reimplantation American Thoracic Society of the American Lung Association Boston, MA, May 1994 Magliato, KE, Swiderski, DL, Kunkel, SL, Wilke, CA, Burdick, MD, Deeb, GM, Strieter, RM. Lung transplantation – a research perspective: historical review, current investigations, and future considerations Akron General Medical Center Resident Research Forum Akron, OH, June 1994


15 Revised 02/13/12

Magliato, KE, Swiderski, DL, Kunkel, SL, Wilke, CA, Burdick, MD, Deeb, GM, Strieter, RM. The role of C-X C chemokines and lung neutrophilia in ischemia-reperfusion injury using a rat lung transplant model

Michigan Society of Thoracic and Cardiovascular Surgeons Lewiston, MI, August 1994

Magliato, KE, Swiderski, DL, Kunkel, SL, Wilke, CA, Burdick, MD, Deeb, GM, Strieter, RM. The expression

of chemokines ENA-78 and GRO during the reimplantation response American Federation of Clinical Research Chicago, IL, September 1994 Magliato, KE, Swiderski, DL, Kunkel, SL, Wilke, CA, Burdick, MD, Deeb, GM, Strieter, RM. The expression

of TNF and chemokines ENA-78 and GRO during ischemia-reperfusion injury associated with lung transplantation Society of University Surgeons Denver, CO, February 1995 Akron General Medical Center Resident Research Forum Akron, OH, June 1995

Magliato, KE, Swiderski, DL, Kunkel, SL, Wilke, CA, Burdick, MD, Deeb, GM, Strieter, RM. Neutralization of

TNF attenuates ischemia-reperfusion injury associated with lung transplantation American College of Surgeons, Midwest Chapter Akron, OH, May 1995 Cleveland Surgical Society Cleveland, OH, March 1995 Magliato, KE. The Novacor and Thoratec Ventricular Assist Devices and their Application University Hospitals of Cleveland Department of Cardiothoracic Surgery Grand Rounds Cleveland, OH, November 1998

Magliato, KE. Ventricular Assist Devices: The University of Pittsburgh Medical Center Experience Cedars Sinai Medical Center Department of Cardiology Grand Rounds Los Angeles, CA, September 1999


16 Revised 02/13/12

Magliato, KE. The Thoratec Ventricular Assist Device: Clinical results and patient considerations

Thoratec Ventricular Assist Device Regional Conference – Invited Speaker Los Angeles, CA, September 1999

Magliato, KE. The Heartmate and Thoratec Ventricular Assist Devices: Bridge to transplant or bridge to recovery?

Cedars-Sinai Medical Center Department of Pulmonary Medicine and Critical Care Grand Rounds Los Angeles, CA, January 2000

Magliato, KE. Cardiovascular Disease in Women

Brotman Hospital Women’s Health Conference Los Angeles, CA, March 2000

Magliato, KE. The Clinical Utilization of Ventricular Assist Devices

Lakeside Medical Group Glendale, CA, February 2000

Valley Presbyterian Hospital Grand Rounds Van Nuys, CA, March 2000

Fountain Valley Regional Medical Center Grand Rounds Fountain Valley, CA, March 2000 Mission Hospital Regional Medical Center Grand Rounds Mission Viejo, CA, June 2000 Healthnet Medical Group Woodland Hills, CA, September 2000

Magliato, KE. The Role of Assist Devices (LVAD, BiVAD) in End-Stage Congestive Heart Failure

State-of-the-Art Management of Heart Failure Symposium Santa Monica, CA, May 2000 Southern California Case Manager’s Symposium Beverly Hills, CA, October 2000 Magliato, KE. The Artificial Heart

Cedars-Sinai Medical Center Cardiovascular Fellows Preceptorship

Los Angeles, CA, March 2001


17 Revised 02/13/12

Magliato, KE. New Technology: The Vented Electric Heartmate Ventricular Assist Device

Cedars-Sinai Medical Center Department of Cardiology Grand Rounds Los Angeles, CA, May 2000 Magliato, KE. Managing Ventricular Assist Device Patients in the Intensive Care Unit

Cedars-Sinai Medical Center Advanced Critical Care Course Los Angeles, CA, September 2000 Magliato, KE. What’s in Your Future? UCLA Medical Center Conference on Career Choices in Medicine - Guest Speaker Los Angeles, CA, January 2001. Magliato, KE. The Care of the Postoperative Thoratec VAD Patient Cedars-Sinai Medical Center Thoratec Training Program Los Angeles, CA, March 2001 Magliato, KE. The Clinical Utilization of Ventricular Assist Devices Long Beach Memorial Medical Center Grand Rounds Presentation Long Beach, CA, April 2001 Magliato, KE. The Current Status of the Artificial Heart University of Southern California Medical Center Department of Cardiology Grand Rounds Los Angeles, CA, April 2001 Magliato, KE. Women and Heart Disease: New Trends in Prevention, Early Diagnosis and Treatments

American Medical Women’s Association Meeting Los Angeles, CA, May 2001


18 Revised 02/13/12

Magliato, KE. The Treatment of Congestive Heart Failure Utilizing the Artificial Heart

State-of-the-Art Management of Heart Failure Symposium Huntington Beach, CA, May 2001 Magliato, KE. Assist Devices as a Bridge to Transplantation Controversies in Adult Cardiac Surgery Conference Los Angeles, CA, October 2001 Magliato, KE. Donor Hearts, Artificial Hearts – Why We Need Them Both! Los Robles Medical Center Grand Rounds Presentation Los Robles, CA, November 2002 Magliato, KE. Don’t Part with Your Heart…Until You Absolutely Have To! Cedars-Sinai Medical Center Transplant Education Conference Los Angeles, CA, November 2001 Magliato, KE. Gadgets and Gizmos – The Technology of the Future Encino-Tarzana Medical Center Grand Rounds Presentation Tarzana, CA, November 2001 Magliato, KE. The Role of Physical Therapy in the Post-Operative Recovery of

Ventricular Assist Device Patients Cedars-Sinai Medical Center Department of Physical Medicine and Rehabilitation Ground Rounds Los Angeles, CA, November 2001 Magliato, KE. An Update on Cardiac Transplantation Cedars-Sinai Medical Center Surgery/Medicine Grand Rounds Los Angeles, CA, December 2001


19 Revised 02/13/12

Magliato, KE. Women and Heart Disease Cedars-Sinai Medical Center Obstetrics/Gynecology Grand Rounds Los Angeles, CA, January 2002 Magliato, KE. LVAD’s, Artificial Hearts and Heart Transplantation California-Nevada Cardiovascular Symposium Las Vegas, NV, March 2002 Magliato, KE. Nesiritide (h-BNP): Implications and Applications in the Cardiac Surgical Patient Cedars-Sinai Medical Center Cardiac Anesthesiology Grand Rounds Los Angeles, CA, April 2002 Magliato, KE. The Physician’s Role in Organ Donation Western Medical Center Surgery/Medicine Grand Rounds Santa Ana, CA, July 2002 Magliato, KE. The Use of the Thoracic Device as a Biventricular Support System The Texas Heart Institute Houston, TX, August 2002 Baylor Methodist Medical Center Los Angeles, CA, October 2002 University of Texas Southwestern Medical Center Dallas, TX, August 2002 Magliato, KE. Restraining Devices in the Treatment of Heart Failure Controversies in Adult Cardiac Surgery Conference II Los Angeles, CA, December 2002 Magliato, KE. The Artificial Heart: A Union of Medicine and Engineering Union College – Keynote Address Schenectady, NY, October 2002


20 Revised 02/13/12

Magliato, KE. Cardiac Mechanical Assist Devices as a Bridge to Transplantation Cedars-Sinai Medical Center Pulmonary Grand Rounds Los Angeles, CA, December 2002 Magliato, KE. New Treatment Options for Heart Failure in the Post Cardiac Surgery Patient University of California, Los Angeles Cardiothoracic Surgery Grand Rounds Los Angeles, CA, December 2002 Magliato, KE. Nesiritide (h-BNP): A Cardiac Surgeon’s Perspective Queens Medical Center Medical Grand Rounds Oahu, Hawaii, January 2003 Saint Francis Medical Center Cardiology Grand Rounds Oahu, Hawaii, January 2003 Children’s Hospital of Los Angeles Pediatric Grand Rounds Los Angeles, CA, February 2003 Saint Jude Medical Center Cardiology Grand Rounds Fullerton, CA, February 2003 California Pacific Medical Center Cardiothoracic Surgery/Cardiology Grand Rounds San Francisco, CA, March 2003 Magliato, KE. Inflammatory Mediators in Cardiac Surgery The Texas Heart Institute Annual Symposium Houston, TX, February 2003 Magliato, KE. The Use of Biventricular Support in Patients in Cardiogenic Shock The Texas Transplant Institute San Antonio, TX, April 2003 Seton Medical Center Austin, TX, April 2003


21 Revised 02/13/12

Magliato, KE. The Surgical Treatment of End-Stage Heart Failure: Destination VAD Therapy Cedars-Sinai Medical Center Pulmonary Grand Rounds Los Angeles, CA, October 2003 Magliato, KE. The Good, the VAD, and the Ugly Texas Transplant Institute 3rd Annual Congestive Heart Failure Symposium San Antonio, TX, February 2004 Advocate Christ Medical Center Medical Grand Rounds Chicago, IL, March 2000 Magliato, KE. Managing the Cardiac Surgery Patient with CHF: a focus on Natriuretic Peptides Kaiser Permanente Hospital Cardiac Surgery Grand Rounds Los Angeles, CA, March 2004 Cedars Sinai Medical Center Medicine Grand Rounds Los Angeles, CA, March 2004 Loma Linda Medical Center Cardiac Surgery Grand Rounds Loma Linda, CA, April 2004 Magliato, KE. The Bikini Approach to Women’s Health Paramount Studios American Heart Association sponsored lecture Hollywood, CA, August 2006 Magliato, KE. The Angina Monologues: Heart Disease in Women The Republican National Convention St. Paul, MN, September 2008

Note: I have given more than 50 lectures on heart disease in women to lay audiences throughout the US from 2008 to 2010


22 Revised 02/13/12

Magliato, KE. Healthcare: A View From the Trenches The Committee of 200 Keynote address Beverly Hills, CA , October 2010 Moderated Sessions at Regional/National Conferences

Controversies in Adult Cardiac Surgery III Session: Surgical Treatment Options for Congestive Heart Failure Los Angeles, CA, October 2003 Society for the Advancement of Blood Management Session: Bloodless Cardiac Operation with live OR audio/video hookup Hollywood, CA, September 2007

CME Satellite Symposiums hosted by National Meeting

American Association for Thoracic Surgery, 84th Annual Meeting Applications and Perspectives: Perioperative Management of the Cardiac Surgery Patient Faculty: R.M. Delgado, O.H. Frazier, K.E. Magliato, N. Moazami Toronto, Canada, April 2004


23 Revised 02/13/12

PUBLICATIONS

Books Healing Hearts: a memoir of a female heart surgeon. Broadway Books division of Random House Inc. © 2010 by Kathy E. Magliato ISBN 978-0-7679-3026-0 *starred review from Publishers Weekly ****4/4 star review in People Magazine (February 15, 2010 issue, page 58)

Articles in Scientific Journals 1. “Management of Arch Hypoplasia after Successful Coarctation Repair.” MM DeLeon, SY DeLeon, JA

Quinones, PT Roughneen, KE Magliato, DA Vitullo, F Cetta, T Bell, EA Fischer. The Annals of Thoracic

Surgery. 1997, 63(4): 975-80. 2. “Simultaneous Repair of Pectus Excavation and Congenital Heart Disease.” MM DeLeon, KE Magliato,

PT Roughneen, L Graham, TM Kudukis and SY DeLeon. The Annals of Thoracic Surgery. 1997, 64(3): 557-59.

3. “The Semilunar Valve Switch Procedure: Autotransplantation of the Native Aortic Valve to the Pulmonary

Position in the Ross Procedure.” PT Roughneen, SY DeLeon, B Eidem, NJ Thomas, F Ceta, DA Vituello,

KE Magliato, TE Berry, M Bakhos. The Annals of Thoracic Surgery. 1999, 67 (3): 745-50. 4. “Heart – Lung Transplantation.” BP Griffith, KE Magliato. Operative Techniques in Thoracic and

Cardiovascular Surgery – A Comparative Atlas. 1999, 4(2): 124-141. 5. “Heart Transplantation – Surgical Results.” KE Magliato, A Trento. Heart Failure Reviews. 2001, 6 (3):

213-219. 6. “Heart Transplantation With Donors Fifty Years of Age and Older.” C Blanche, A Kamlot, DA Blanche, B

Kearney, KE Magliato, L SC Czer, A Trento. The Journal of Thoracic and Cardiovascular Surgery. 2002, 123: 810-815.

7. “Off Pump Coronary Surgery: Effect on Early Mortality and Stroke.” W Cheng, TA Denton, GP Fontana, S

Raissi, CA Blanche, RM Kass, KE Magliato, A Trento. The Journal of Thoracic and Cardiovascular

Surgery. 2002, 124:313-320. 8. “Biventricular Support in Patients with Profound Cardiogenic Shock: A Singular Center Experience.” KE

Magliato, T Kleisli, R Tabrizi, HJ Soukiasian, BL Coleman, A Hickey, LS Czer, CA Blanche, W Cheng, GP Fontana, RM Kass, SS Raissi, A Trento. ASAIO Journal. 2003, 49(4):475-479.


24 Revised 02/13/12

9. “A Novel Sub-Population of Bone Marrow-Derived Myocardial stem Cells: Potential Autologous Cell Therapy in Myocardial Infarction.” HJ Soukiasian, LSC Czer, I Avital, T Aoki, Y Kim, Y Umehara , J Pass, R Tabrizi, KE Magliato, G Fontana, W Cheng, A Demetriou, A Trento. The Journal of Heart and Lung Transplantation. 2004. 23:873-880.

10. “Ischemic Mitral Regurgitation: Revascularization alone versus Revascularization and Mitral Valve Repair.”

Y Kim, LSC Czer, HJ Soukiasian, M De Robertis, KE Magliato, CA Blanche, SS Raissi, J Mirocha, RJ Siegel, RM Kass, A Trento. Annals of Thoracic Surgery. 2005, 79:1895-1901.

11. “In the Current Era, Complete Revascularization Improves Survival After Coronary Artery Bypass Surgery.” T Kleisli, W Cheng, M Jacobs, J Mirocha, M Michele, M DeRobertis, R Kass, C Blanche, G Fontana, S Raissi, KE Magliato and A Trento. The Journal of Thoracic and Cardiovascular Surgery. 2005, 129:1283-1291.

12. “Laparoscopic Cholecystectomy in a Patient With a Biventricular Cardiac Assist Device.” N Nissen, J

Korman, T Kleisli, KE Magliato. The Journal of the Society of Laparoendoscopic Surgeons. 2005, 9: 481-484.

Chapters 1. KE Magliato, M Oddi, D Moorman. “Thoracic Outlet Syndrome.” In: The 5-Minute Clinical Consult. HW

Griffith and M Dambro (eds.) Lea and Febiger, Philadelphia, Pennsylvania and London, England. 1993.

2. KE Magliato, BP Griffith. “Lung Transplantation and Extracorporeal Life Support”. In: ECMO, Exracorporeal Cardiopulmonary Support in Critical Care. JB Zwischenberger and RH Bartlett (eds). 2000.

Abstracts 1. “Primate Spinal Reflexes after Cord Transection: Absence of Depression.” KE Magliato, PA Noonan, JR

Wolpaw. (Oral presentation at the 1986 16th Annual Meeting of the Society for Neuroscience). 2. “Characterization of the Natural Killer Cell Activity Released from Proliferating Human Lymphocytes in the

Presence of Interleukin-2.” KE Magliato, CF Lane, JR Mehta. (Oral presentation at the 1988 AMA Education and Research Foundation Eastern Student Research Forum and the 1988 Associated Medical Schools of New York Research Forum).

3. “The Role of C-X-C Chemokines and Lung Neutrophilia in Ischemic-Reperfusion Injury Using a Rat Lung Transplant Model.” KE Magliato, DL Swiderski, SL Kunkel, CA Wilke, MD Burdick, GM Deeb, RM Strieter. (Oral presentation at the 1994 Michigan Society of Thoracic and Cardiovascular Surgeons Meeting).

4. “The Expression of TNF and Chemokines ENA-78 and GRO During Ischemia - Reperfusion Injury Associated with Lung Transplantation.” KE Magliato, DL Swiderski, SL Kunkel, CA Wilke, MD Burdick, GM Deeb, RM Strieter. (Oral presentation at the 1994 American Federation of Clinical Research Meeting).


25 Revised 02/13/12

5. “The Expression of Chemokines ENA-78 and GRO During the Reimplantation Response.” KE Magliato, DL Swiderski, SL Kunkel, CA Wilke, MD Burdick, GM Deeb, RM Strieter. (Oral presentation at the 1994 American Federation of Clinical Research Meeting).

6. “Neutralization of TNF- Attenuates Ischemia-Reperfusion Injury Associated with Lung Transplantation.” KE Magliato, DL Swiderski, SL Kunkel, CA Wilke, MD Burdick, GM Deeb, RM Strieter. (Oral presentation at the 1995 American College of Surgeons, Ohio Chapter).

7. “IL-6 and TNF- Genotypes Predicts Acute Rejection and Lower Survival in African American Heart Transplant Recipients.” BL Coleman, LSC Czer, SC Jordan, J Mirocka, G Gillaspie, CA Blanche, A Hickey, KE Magliato, DB Tyan. (Oral presentation at the 2002 American Society for Histocompatibility and Immunogenetics, Nashville, TN).

8. “The Use of Biventricular Support in Patients with Profound Cardiogenic Shock: A Single Center

Experience.” KE Magliato, T Kleisli, R Tabrizi, HJ Soukiasian, BL Coleman, A Hickey, LSC Czer, CA Blanche, W Cheng, GP Fontana, RM Kass, SS Raissi, A Trento. (Poster presentation at the American Society for Artificial Internal Organs, 2002 Meeting).

9. “Thoracic Aortic Repair in the Octogenarian Population.” HJ Soukiasian, SS Raissi, KE Magliato, T Kleisli,

LSC Czer, RM Kass, A Trento. (Poster presentation at the 2002 Aortic Surgery Symposium VIII).

10. “Total Circulatory Arrest for the Replacement of the Descending and Thoracoabdominal Aorta.” T Kleisli, SS Raissi, HJ Soukiasian, RM Kass, KE Magliato, W Cheng, GP Fontana, A Wong, YH Kim, R Tabrizi, A Trento. (Poster presentation at the 2002 Aortic Surgery Symposium VIII).

11. “A Novel Sub-population of Bone Marrow Derived Myocardial Stem Cells: Potential Autologous Cell

Therapy in Myocardial Infarction.” HJ Soukiasian, LSC Czer, I Avital, T Aoki, Y Kim, Y Umehara, J Pass, R Tabrizi, KE Magliato, GP Fontana, W Cheng, A Demetriou, A Trento. (Oral presentation at the International Society for Heart and Lung Transplantation Meeting, 2003).

12. “IL-6 and TNF- Cytokine Genotypes are Associated with Acute Rejection and Lower Survival in African-American Heart Transplant Recipients.” BL Coleman, LSC Czer, SC Jordan, J Mirocka, G Gillaspie, CA Blanche, A Hickey, KE Magliato, DB Tyan. (Oral presentation at the International Society for Heart and Lung Transplantation Meeting, 2003).

13. “Functional Recovery of Heart Failure Patients in Cardiogenic Shock Treated with Paracorporeal

Biventricular Support.” CH Vogel, BL Coleman, LJ Ernst, T Kleisli, KE Magliato. (Poster presentation at the International Society for Heart and Lung Transplantation Meeting, 2003).

14. “Ischemic Mitral Regurgitation: Revascularization alone versus Revascularization and Mitral Valve Repair.”

Y Kim, LSC Czer, KE Magliato, HJ Soukiasian, M DeRobertis, CA Blanche, SS Raissi, RM Kass, M Sandhu, RJ Siegel, A Trento. (Oral presentation at the Second International Symposium on Ischemic Mitral Regurgitation, 2003).

15. In the Current Era Complete Revascularization Improves Survival Following Coronary Artery Bypass

Surgery.” T Kleisli, W Cheng, M Jacobs, J Mirocha, M DeRobertis, R Kass, C Blanche, G Fontana, S Raissi, K Magliato and A Trento. (Oral presentation at the Western Thoracic Surgical Association Meeting, 2004)


26 Revised 02/13/12

Electronic Publications

1. “Ventricular Assist Device Advances with Kathy Magliato, M.D.” WebMD Website. April, 2000. 2. “The Role of Passive Restraining Devices in the Treatment of Congestive Heart Failure: The ACORN

Device.” [essay]. Cardiosource Website, American College of Cardiology Foundation and Elsevier Inc. June, 2003.

Invited Commentaries

1. “Reverse Remodeling of the Failing Ventricle: Surgical Intervention with the ACORN Cardiac Support

Device.” MC Oz, WF Konertz, J Raman, FX Kleber. Congestive Heart Failure, 2003.


27 Revised 02/13/12

IRB PROTOCOLS: PRINCIPLE INVESTIGATOR

1. “Clinical Evaluation of the Thoratec® Implantable Ventricular Assist Device (IVAD)”

Specific Aims:

To demonstrate that the Thoratec® IVAD, when used with either the Dual Drive Console or the TLC-II Portable Driver is safe and effective for either a bridge to transplant or VAD support pending myocardial recovery. Patients may be discharged to home with the IVAD in place. This is a multicenter, prospective controlled clinical trial conducted according to a common protocol. Ten U.S. study sites will be involved.

2. “Clinical Evaluation of the ACORN Cardiac Support Device Therapy in Patients with Dilated

Cardiomyopathy"

Specific Aims:

This is a prospective, randomized, unblinded, parallel group evaluation of the Acorn Cardiac Support Device therapy in patients with dilated cardiomyopathy of either ischemic or non-ischemic origin, who may or may not need concomitant mitral valve repair/replacement. The study is intended to assess the safety and efficacy of the Acorn Cardiac Support Device. 300 patients will be enrolled at 20 U.S. centers.

3. “Assessing Endothelial Dysfunction Utilizing Calibrated Cuff Plethysmography” Specific Aims:

This is a prospective, non-randomized single-center study to evaluate a medical device known as the Calibrated Cuff Plethysmograph. The device can measure endothelial dysfunction (ED) and provide an actual measurement as opposed to an estimate of ED. The device is a non-invasive , non-imaging device. 100 patients with known cardiovascular disease will be tested.


28 Revised 02/13/12

IRB PROTOCOLS: CO-INVESTIGATOR

1. “A Phase II Randomized Multicenter Clinical Study to Evaluate the Safety and Efficacy of the Tandem HeartTM pVAD System versus Conventional Therapy for the Treatment of Cardiogenic Shock.”

Specific Aims: To evaluate the efficacy of the Tandem HeartTM pVAD System in providing effective circulatory support to stabilize patients who are in persistent cardiogenic shock despite maximum medical management. Ninety patients will be randomized at up to 20 centers. Control patients will be supported with an IABP and medical management.

2. “Safety and Hemodynamic Effect of Nesiritide in Postoperative Cardiac Surgical Patients.” Specific Aims: This is an open label study of the administration of fixed dose Nesiritide on the hemodynamics of cardiac surgery patients. The major goal is to establish the safety of administering Nesiritide to post- cardiac surgery patients and the degree of benefit.

3.“A Prospective, Observational Evaluation of the SJM Epic Porcine Valve”

Specific Aims:

The purpose of this study is to monitor and record the performance and durability of a new porcine aortic valve which is processed with glutarldehyde and treated with ethanol in a process called Linx ™. 300 patients will be enrolled at 20 sites in the United States and Canada. Patients will be followed for five years.

4. “A Pharmacodynamic Approach to Immune Monitoring”

Specific Aims:

To define a quantitative relationship between cyclosporine blood levels and inhibition of peripheral and intragraft lymphocytes in recipients of cardiac and pulmonary allografts.

To define a relationship between blood cyclosporine levels and inhibition of the mixed lymphocyte

reaction in recipients of cardiac and pulmonary allografts.


29 Revised 02/13/12

5. “A Two-Year Randomized, Multicenter, Double-blind Study of the Efficacy and Safety of SDZ RAD Versus Azathioprine as part of a Triple Immunosuppressive Therapy Regimen in DeNovo Heart Transplant Recipients”

Specific Aims:

To compare the efficacy of two oral doses (0.75 and 1.5 mg/bid) of RAD001 (an oral analog of rapamycin) with azathioprine in addition to Neoral and steroids in de novo heart transplant recipients as measured by the incidence of death, graft loss/retransplant, biopsy proven acute rejection episode

Grade > 3A or any clinically suspected acute rejection episode associated with hemodynamic compromise in the first 6 months post transplant.

6. “Aortic Comparative Trial: A Randomized Comparison of Stentless Versus Stented Aortic Valve

Replacements”

Specific Aims:

To compare, in a randomized fashion, the hemodynamic characteristics and patient outcomes of both the Torono SPV stentless valve and stented pericardial or porcine valves. Patients will be followed by echocardiogram at 6 months, 1 year, 2 years and 5 years after surgery.

7. “Transmyocardial Revascularization (TMR) Using the Heart Laser CO2 System: A Post-Market Study”

Specific Aims:

To monitor the outcomes of patients treated with TMR in order to gain a better understanding of the risks associated with the treatment. Patients will be followed postoperatively at 30 days and 1 year. Patients included in the study will have stable CCS class 3-4 angina refractory to medical management.

They must also have objectively demonstrated coronary artery atherosclerosis, which is not amenable to direct coronary revascularization.


30 Revised 02/13/12

8. “Phase II Randomized Study of H5g1.1-Scfv: Outcomes in Patients Undergoing Cardiopulmonary Bypass”

Specific Aims:

Anti-human C5a has been shown to down-regulate pro-inflammatory activity in the animal model and dramatically reduce cardiac tissue injury and infarct size in ischemic myocardium. It similarly reduces cerebral swelling and infarct size. This study will compare the effects of H5g1.1-Scfv, an anti-human C5a complement antibody, to placebo in patients undergoing non-emergent heart surgery. Patients will be assigned to one of three groups to receive either a) placebo, or b) H5g1.1-Scfv IV over 10 min. at 2mg/kg or c) H5g1.1-Scfv IV over 10 min. at 2mg/kg followed by H5g1.1-Scfv infusion over 24 hours at 0.5mg/kg/hr. Routine blood tests will be obtained preoperatively and periodically during patient hospitalization and at 30 days following surgery with additional tests to measure the antibody. Neuropsychological tests will be administered pre and postoperatively and any adverse events will be monitored and recorded.

9. “Phase IV Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Fenoldopam Mesylate in Preserving Renal Function and its Potential Effects on Postoperative Morbidity”

Specific Aims:

The objective of this drug study is to evaluate the effect of fenoldopam mesylate in comparison to placebo on primary and secondary efficacy outcomes. The primary outcome is preserving renal function after CABG. Secondary outcomes are postoperative mortality, cardiac morbidity, stroke and cognitive function. We will also evaluate the safety of intravenous administration of the study drug in comparison to placebo.

The study drug is a known renal and systemic vasodilator. Effects of fenoldopam mesylate as a coronary vasodilator and its ability to increase cardiac output in cardiac surgery patients warrant study of this agent in heart failure and myocardial ischemia. The study drug may also reduce the effects of decreased blood flow to the brain during bypass and, by doing so, reduce mental dysfunction postoperatively.

10. “Acupuncture Following Cardiac Surgery: A Pilot Study”

Specific Aims:

Acupuncture is a known technique used for the treatment of a variety of conditions including pain and discomfort. The uses of therapies such as acupuncture are widely used in Asian countries and are now becoming increasingly practiced throughout the world including the United States. Although acupuncture is frequently used as a “sole” treatment, it is beginning to be used in conjunction with standard “Western” medical treatments. Once a suitable way of integrating acupuncture into the


31 Revised 02/13/12

clinical setting has been developed, we will embark on designing a larger study to assess the efficacy of acupuncture for specific patient needs.

11. “Guided Imagery Before, During and After Cardiac Surgery: A Pilot Study”

Specific Aims:

Guided imagery involves a variety of techniques. The use of imagery techniques is based on the assumption that relaxation associated with imagining a relaxing environment can, in part, alleviate physical tension and anxiety which directly influences a patient’s perception and tolerance to pain. Once a suitable way of integrating guided imagery techniques into the clinical setting has been developed; we will embark on designing a larger study to assess the efficacy of guided imagery for specific patient needs.

12. “The Ross Aortic Valve Replacement Procedure: A Postoperative Follow-Up Study”

Specific Aims: To document the long-term results of the Ross Procedure in patients who suffer from aortic valve disease. Patients will be followed post-operatively by echocardiography.

13. “The Effect of Elevated Preoperative Pulmonary Vascular Resistance on Heart Transplant Recipients: a

single center experience.”

Specific Aims:

The purpose of this study is to evaluate the effect of pre-transplant elevated pulmonary vascular resistance (PVR) on the clinic outcome of heart transplant recipients. Hemodynamic measurement of cardiac performance, valve dysfunction, rejection rates, readmission rates and exercise tolerance will be compared between patients with a PVR >3.0 Wood units and patients with a PVR <3.0 Wood units.

14. “An Acute Porcine FocalSeal-L Lung Sealant Training Laboratory for Surgeons and Sales Representatives.”


32 Revised 02/13/12

PATENTS “METHOD AND DEVICE FOR DETECTING AND ASSESSING REACTIVE HYPEREMIA USING SEGMENTAL PLETHYSMOGRAPHY”

International Application Number: PCT/US2010/001605 Filing Date: June 2, 2010 United States Application Number: 61/208,547 Filing date: February 26, 2009

BOARD MEMBERSHIP 2006 – present: Greater Los Angeles County American Heart Association 2010 – 2012: President, American Heart Association Greater LA County Board of Directors 2006 – present: Union College Board of Trustees 2009 – present: Events of the Heart Board of Trustees 2010 – present: My Wellness Expert Board of Directors 2010 – present: World Medical Care Mission – controlling interest (501c3)

CORPORATIONS 2004 – present: Kathy Elizabeth Magliato MD, Inc. (C – corp, EIN: 20-1700830), President and CEO 2009 – present: Cordex Systems, LLC. (LLC, EIN: 26-4689972), Chief Medical Officer

INDUSTRY CONSULTING

Jarvik Heart Inc. New York, NY, Chairman of the Clinical Events Committee Cardiomag Inc. Schenectady, NY Tagnos Inc. Ladera Ranch, CA ABC studios Grey’s Anatomy: character consulting for actors: Mary Mcdonnell, Brooke Smith and Kim Raver


33 Revised 02/13/12

MEDIA APPEARANCES

Television

1. Barbara Walters 20/20 interview on heart disease with President Bill Clinton, David Letterman and Robin Williams

2. National Geographic Explorer: “The Moment of Death”

3. The Doctors (CBS) – segment:“Long QT syndrome in women”

4. The Doctors (CBS) – segment: “The relationship between PAD and heart disease in women” 5. Lifetime Network – Documentary: “Every Woman.” 6. Discovery Channel – Documentary: “Medical Story.” 7. NBC iVillage live – segment: “Heart Disease in Women” 8. Lifetime Network – Series: “Speaking of Women’s Health.”

9. DHTV – “People Making a Difference” hosted by Danny Brassell

10. Press Conference at Cedars-Sinai Medical Center: The Artificial Heart, aired on CBS, NBC, ABC and

FOX. (August 1, 2001 – Cedars-Sinai Medical Center, Los Angeles, CA) 11. NBC News Segment with Bruce Hensel: “The ACORN Device.” 12. American Institute of Physics – Discovery Segment: “The ACORN Cardiac Support Device.” 13. Med Star Television – News Segment: “The ACORN Cardiac Support Device.” 14. LA talk show “Coffee Break” – Topic: Heart Disease in Women (part one) 15. LA talk show “Coffee Break” – Topic: Heart Disease in Women (part two)

Radio/Internet 1. WebMD – live online interview: “Ventricular Assist Devices.” 2. WebMD – interview and live intra-operative surgery video: “Heart Disease in Women”


34 Revised 02/13/12

3. Greenstone Media: The Rolanda Show. Topic: Heart Disease in Women 4. Greenstone Media: Women Aloud. Topic: Heart Disease in Women 5. KABC News Station – live interview: – “Ventricular Assist Devices.”

6. NewsRx.com – interview: “Congestive Heart Failure: Investigational Mesh ‘Jackets’ Studied as an Experimental Therapy.”

7. Medical Devices and Surgical Technology Week: “Congestive Heart Failure: Investigational Mesh

‘Jackets’ Studied as an Experimental Therapy.” 8. Heart Disease Weekly: “Congestive Heart Failure: Investigational Mesh ‘Jackets’ Studied as an

Experimental Therapy.”

Newspaper/Newsletter 1. Los Angeles Times press release: “Specialist Joining Cardiothoracic Surgery Department at Cedars-

Sinai Medical Center Increases Strength of Heart Transplant Program.” 2. Los Angeles Times front page article: “Women: Vast Changes in Medicine.” 3. Los Angeles Times article: “Taking His New Heart for a Walk.” 4. Los Angeles Daily News article: “Saved by a New Type of Life Net – The ACORN Device.” 5. Fort Lauderdale Sun Sentinel article: “Saved by a New Type of Life Net – The ACORN Device.” 6. Chicago Tribune article: “Saved by a New Type of Life Net – The ACORN Device.” 7. Houston Chronicle article: “Saved by a New Type of Life Net – The ACORN Device.” 8. Daily Breeze front page article: “A New Heart; A New Start.” 9. Antelope Valley News front page article: “Saved by a New Type of Life Net – The ACORN Device.” 10. Antelope Valley News front page article: “Life-changing Surgery.” 11. Today in Cardiology Newsmagazine, Volume 5 Number 10: “Clinical Trial of ‘Mesh ‘Jackets’ for Heart

Failure Begins.” 12. RT Image Newsmagazine, Volume 15 Number 40: “Mesh ‘Jackets’ Offer New Therapy for Heart Failure

Patients.” 13. UNOS Newsletter: “Who’s Going Where?” 14. American Medical Women’s Association: “Women in Medicine” profile.


35 Revised 02/13/12

15. Los Angeles County Medical Women’s Association Newsletter: “New Member Profile.” 16. Association of Women Surgeons Newsletter: “Women on the Move.” 17. Medical Devices and Surgical Technology Week: “Congestive Heart Failure: Investigational Mesh

‘Jackets’ Studied as an Experimental Therapy.” 18. Heart Disease Weekly: “Congestive Heart Failure: Investigational Mesh ‘Jackets’ Studied as an

Experimental Therapy.” 19. Brotman Hospital Newsletter: “Who’s Going Where?” 20. Cedars-Sinai Medical Center Newsletter: “Cedars-Sinai Takes a Leading Role in Transplantation.”


36 Revised 02/13/12

CURRENT RESEARCH INTERESTS

Heart disease in women.

Congestive heart failure.

Ventricular assist devices.

Cardiopulmonary transplantation.

Ischemia reperfusion injury.

Cytokine biology.

CONTINUING MEDICAL EDUCATION ACTIVITIES

- American Association for Thoracic Surgery San Diego, CA 2008 - Society for the Advancement of Blood Management Hollywood, CA 2007 - Topics in Pain Management (CA state requirement) Self Study Program 2006 - American College of Surgeons Southern California Chapter Santa Barbara, CA 2006 - American College of Surgeons 91st Clinical Congress San Francisco, CA 2005 - Texas Heart Institute Implantable LVAD conference Houston, TX 2004

- American Association for Thoracic Surgery Toronto, Canada 2004 - International Society for Heart & Lung Transplantation Meeting San Francisco, CA 2004 - Mitral Valve Repair (Club Mitrale – Carpentier) XII Meeting Los Angeles, CA 2003 - ACORN Principle Investigators Meeting New York, NY 2002 - Controversies in Adult Cardiac Surgery II Los Angeles, CA 2002 - STS Heart Failure and Circulatory Support Summit Cleveland, OH 2002 - American Society for Artificial Internal Organs New York, NY 2002 - Thoratec® Investigators and Users Meeting Scottsdale, AZ 2002 - ISHLT Mechanical Cardiac Support and Replacement II Anaheim, CA 2001

- Controversies in Adult Cardiac Surgery Los Angeles, CA 2001 - International Society for Heart & Lung Transplantation Meeting Vancouver, CAN 2001 - 5th STS International Conference on Circulatory Support New York, NY 2000 - 13th Annual HeartMate Investigators and Users Meeting Miami, FL 2000 - International Society for Heart & Lung Transplantation Meeting Osaka, Japan 2000 - ISHLT Mechanical Cardiac Support and Replacement I Atlanta, GA 1999 - Society of Thoracic Surgeons 34th Annual Meeting New Orleans, LA 1998 - St. Jude Toronto SPV Valve Symposium Chicago, IL 1998 - St. Jude Cardiac Surgery Symposium for Thoracic Surgery Fellow Minneapolis, MN 1998 - Medtronic Octopus Tissue Stabilization System Symposium Chicago, IL 1998 - Medtronic Stentless Valve Symposium Chicago, IL 1998 - International Heart Institute of Montana Valve Symposium Missoula, MT 1997 - American College of Surgeons Meeting Chicago, IL 1997 - Society of Thoracic Surgeons 32nd Annual Meeting Orlando, FL 1996


37 Revised 02/13/12

PERSONAL

Husband: Nicholas N. Nissen, MD Associate Professor UCLA Medical Center Staff Surgeon, Department of Surgery, Cedars Sinai Medical Center Director of Hepatobiliary Surgery, Cedars Sinai Medical Center Assistant Director Liver Transplantation, Cedars Sinai Medical Center Training: College: University of Minnesota Medical School: University of Minnesota General Surgery Residency: Loyola University Medical Center (board certified) Critical Care Fellowship: University of Pittsburgh Medical Center (board certified) Liver Transplant Fellowship: UCLA Medical Center

kathy elizabeth magliato, md, mba, facs · kathy elizabeth magliato, md, mba, facs 5 revised...

Documents